A measure of tear inflow in habitual scleral lens wearers with and without midday fogging.


Journal

Contact lens & anterior eye : the journal of the British Contact Lens Association
ISSN: 1476-5411
Titre abrégé: Cont Lens Anterior Eye
Pays: England
ID NLM: 9712714

Informations de publication

Date de publication:
02 2019
Historique:
received: 07 04 2018
revised: 08 10 2018
accepted: 15 10 2018
pubmed: 21 11 2018
medline: 4 4 2020
entrez: 21 11 2018
Statut: ppublish

Résumé

The purpose of this pilot study was to evaluate tear inflow in a scleral lens system using fluorophotometry, and indirectly assess the exchange of the tear reservoir in habitual scleral lens wearers with the presence or absence of midday fogging (MDF). Habitual scleral lens wearers (n=23) and normal scleral lens neophytes (n=10) were recruited. Of the 23 habitual wearers, 11 of them experienced MDF and 12 did not have a diagnosis of MDF. Contact lens-fitting characteristics were evaluated using ocular coherence tomograpy (OCT) and biomicroscopy. High molecular weight fluorescein (FITC) Dextran was instilled into the tear reservoir beneath the scleral lens, and the tear fluid fluorescein concentration was measured using the Fluorotron fluorophotometer. Calculated fluorescein concentrations were plotted over time to measure the fluorescein decay rate of the tear fluid beneath the scleral lens, which was used to calculate the tear exchange rate. There was no significant difference in tear inflow between the MDF group (mean: 0.111%) and the non-MDF group (mean: 0.417%), and there was a high amount of variability seen in the rates (p = 0.26). In addition, there was no significance between the tear reservoir thickness in the MDF (283um) and non-MDF (326um) groups (p = 0.53). The relationship between the amount of tear exchange during scleral lens wear and the incidence of MDF was not significant. Additional studies are needed to further examine the role of tear exchange in MDF and address the causes of variability to improve measurement techniques with fluorophotometry in the scleral lens system.

Identifiants

pubmed: 30455083
pii: S1367-0484(18)30518-6
doi: 10.1016/j.clae.2018.10.009
pmc: PMC6340712
mid: NIHMS1512956
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-42

Subventions

Organisme : NEI NIH HHS
ID : P30 EY007551
Pays : United States
Organisme : NEI NIH HHS
ID : T35 EY007088
Pays : United States

Informations de copyright

Copyright © 2018 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Références

Cont Lens Anterior Eye. 2012 Aug;35(4):189-92
pubmed: 22459875
Cont Lens Anterior Eye. 2004 Mar;27(1):15-20
pubmed: 16303522
Invest Ophthalmol Vis Sci. 1999 Feb;40(2):542-6
pubmed: 9950618
Eye Contact Lens. 2005 May;31(3):96-104
pubmed: 15894874
Cornea. 1992 Nov;11(6):515-7
pubmed: 1468213
Br J Ophthalmol. 1995 Nov;79(11):1042-5
pubmed: 8534651
J Optom. 2015 Jan-Mar;8(1):2-11
pubmed: 25575892
Cont Lens Anterior Eye. 2012 Dec;35(6):266-71
pubmed: 22878418
Optom Vis Sci. 2014 Dec;91(12):1462-6
pubmed: 25279781
Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2813-20
pubmed: 11687522
Cont Lens Anterior Eye. 2016 Apr;39(2):88-96
pubmed: 26341076
Invest Ophthalmol Vis Sci. 1979 Apr;18(4):409-13
pubmed: 429114
Am J Ophthalmol. 1999 Jun;127(6):659-65
pubmed: 10372875
Optom Vis Sci. 2001 Jan;78(1):30-6
pubmed: 11233332
Graefes Arch Clin Exp Ophthalmol. 1985;222(4-5):209-11
pubmed: 3979845
Br J Ophthalmol. 1970 Jul;54(7):486-9
pubmed: 5433353
Optom Vis Sci. 1998 May;75(5):316-22
pubmed: 9624695
Eye Contact Lens. 2003 Jan;29(1 Suppl):S90-2; discussion S115-8, S192-4
pubmed: 12772740
Cont Lens Anterior Eye. 2015 Jun;38(3):145-7
pubmed: 25863566
Med Biol Eng Comput. 1979 May;17(3):365-70
pubmed: 317334
Br J Ophthalmol. 2002 Jun;86(6):616-9
pubmed: 12034680
Invest Ophthalmol Vis Sci. 1980 Nov;19(11):1397-1400
pubmed: 7429777
Eye Contact Lens. 2018 Mar;44(2):97-101
pubmed: 29369227
Eye Contact Lens. 2012 May;38(3):179-82
pubmed: 22543730
J Biomech. 1974 May;7(3):225-38
pubmed: 4846263
Invest Ophthalmol. 1966 Jun;5(3):264-76
pubmed: 5947945
Br J Ophthalmol. 1977 Nov;61(11):722-5
pubmed: 588528
Clin Ophthalmol. 2015 Oct 28;9:2013-8
pubmed: 26604671

Auteurs

Kelsea V Skidmore (KV)

Texas Eye Research and Technology Center, University of Houston, College of Optometry, 4901 Calhoun Rd, Houston, TX, United States. Electronic address: drskidmore@familyvisionsolutions.com.

Maria K Walker (MK)

Texas Eye Research and Technology Center, University of Houston, College of Optometry, 4901 Calhoun Rd, Houston, TX, United States.

Jason D Marsack (JD)

Texas Eye Research and Technology Center, University of Houston, College of Optometry, 4901 Calhoun Rd, Houston, TX, United States.

Jan P G Bergmanson (JPG)

Texas Eye Research and Technology Center, University of Houston, College of Optometry, 4901 Calhoun Rd, Houston, TX, United States.

William L Miller (WL)

University of the Incarnate Word, Rosenberg School of Optometry, San Antonio, TX, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH